ESF-26163-70669
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 282 / NC
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-25
- 2021-03-27
-
2021-03-29
Health check-in — day 7, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-05
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-15
- 2021-04-18
- 2021-05-04
- 2021-05-12
- 2021-05-27
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Ageusia, Anosmia, Fatigue, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion, runny nose, fatigue, and unable to smell or taste.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-22
-
2021-10-12
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous, Anosmia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Loss of smell Pregnancy lossMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-10-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-13 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-10-12 | Successful 2021-10-13 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 3 months, dose 2
Symptoms: Congestion, runny nose, fatigue, and unable to smell or taste.
Release 10 — 6 months, dose 2
Symptoms: Loss of smell Pregnancy loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release